Clinical Trial Update: Prednisolone in Active Ankylosing Spondylitis (AS) [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update investigates prednisolone for active ankylosing spondylitis in Phase 2 and Phase 3; the current status of the trial is not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Prednisolone (Prednisolone)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Ankylosing Spondylitis | Phase 2, Phase 3 | Status: UNKNOWN